Jan 18 (Reuters) - Daiichi Sankyo Inc, the U.S. subsidiary of Japan's Daiichi Sankyo Co Ltd (4568.T), said U.S. health regulators approved its cholesterol drug Welchol to reduce blood glucose in adults with type 2 diabetes.
Welchol is now the first and only medication approved to reduce both glucose and cholesterol levels, the company said in a statement. (Reporting by Jennifer Robin Raj in Bangalore; Editing by Deepak Kannan)
BAGHDAD (Reuters) - Iraq expressed its disappointment on Friday with a U.S. federal court ruling that threw out all charges against five Blackwater Worldwide security guards accused of gunning down Iraqi civilians in 2007.
Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch. Full Article
From polar bears to emperor penguins, endangered species will get top online billing in 2010 during the Year of Biodiversity. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
